Recent Updates
Recently added Catalysts
SRTS Positive Sentiment

Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024

Key Takeaway: Sensus Healthcare, Inc. will hold a conference call on August 8, 2024, to discuss its financial results for the second quarter of 2024. During this call, management will also provide a business update and discuss recent and upcoming milestones. The call will be accessible via pre-registration and will be webcast live. Following the call, a replay will be available for a limited time.
Price reaction · baseline $6.35 (2024-07-24 close) · hit after-hours · clean, no other SRTS news in the window
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Company is hosting a call to discuss upcoming milestones.
  • Sensus Healthcare is focused on innovative, non-invasive treatment solutions.
  • Management's proactive engagement with investors indicates good communication.

Full Press Release Details

BOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may access the conference call by dialing, 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until September 8th, and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International).  At the system prompt, dial the replay code – 2699495 – followed by the # sign. Playback will automatically begin. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.

Frequently Asked Questions

When is the Sensus Healthcare conference call scheduled?

The conference call is on August 8, 2024, at 4:30 p.m. Eastern time.

How can I participate in the Sensus Healthcare call?

Participants can pre-register online or dial in at 844-481-2811 or 412-317-0676.

Will the conference call be available to listen later?

Yes, a telephone replay will be accessible until September 8, 2024.

What is Sensus Healthcare known for?

Sensus Healthcare specializes in non-invasive treatments for skin cancer and keloids.

Where can I find more about Sensus Healthcare?

More information is available on their official website, www.sensushealthcare.com.

Last updated: Jul 25, 2024